Cargando…

Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma

Background: Radiofrequency ablation (RFA) is a curative modality for hepatocellular carcinoma (HCC) patients who are not suitable for resection. It remains controversial whether a surgical or percutaneous approach is more appropriate for HCC. Method: A search was performed on the PubMed, Web of Scie...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaozhun, Liu, Yibin, Xu, Lin, Ma, Teng, Yin, Xin, Huang, Zhangkan, Wang, Caibin, Huang, Zhen, Bi, Xinyu, Che, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763842/
https://www.ncbi.nlm.nih.gov/pubmed/35059430
http://dx.doi.org/10.3389/fsurg.2021.788771
_version_ 1784634039495294976
author Huang, Xiaozhun
Liu, Yibin
Xu, Lin
Ma, Teng
Yin, Xin
Huang, Zhangkan
Wang, Caibin
Huang, Zhen
Bi, Xinyu
Che, Xu
author_facet Huang, Xiaozhun
Liu, Yibin
Xu, Lin
Ma, Teng
Yin, Xin
Huang, Zhangkan
Wang, Caibin
Huang, Zhen
Bi, Xinyu
Che, Xu
author_sort Huang, Xiaozhun
collection PubMed
description Background: Radiofrequency ablation (RFA) is a curative modality for hepatocellular carcinoma (HCC) patients who are not suitable for resection. It remains controversial whether a surgical or percutaneous approach is more appropriate for HCC. Method: A search was performed on the PubMed, Web of Science, Embase, and Cochrane Library databases from the date of database inception until April 17, 2021. Studies reporting outcomes of comparisons between surgical RFA (SRFA) and percutaneous RFA (PRFA) were included in this study. The meta-analysis was performed using the Review Manager 5.3 and Stata 12.0 software. Result: A total of 10 retrospective studies containing 12 cohorts, involving 740 patients in the PRFA group and 512 patients in the SRFA group, were selected. Although the tumor size in PRFA group was smaller than the SRFA group (p = 0.007), there was no significant difference in complete ablation rate between the SRFA and PRFA groups (95.63% and 97.33%, respectively; Odds ratio [OR], 0.56; 95% confidence intervals [CI], 0.26–1.24; p = 0.15). However, the SRFA group showed a significantly lower local tumor recurrence than the PRFA group in the sensitivity analysis (28.7% in the PRFA group and 21.79% in the SRFA group, respectively; OR, 1.84; 95% CI, 1.14–2.95; p = 0.01). Pooled analysis data showed that the rate of severe perioperative complications did not differ significantly between the PRFA and SRFA groups (14.28% and 12.11%, respectively; OR, 1.30; 95% CI, 0.67-2.53; p = 0.44). There was no significant difference in the 1-, 3-, and 5-year overall survival rates, as well as the 1- and 3-year disease-free survival (DFS) between the PRFA and SRFA groups. The 5-year DFS of the PRFA group was significantly lower than the SRFA group (hazard ratio 0.73; 95% CI 0.54–0.99). Conclusion: Based on our meta-analysis, the surgical route was superior to PRFA in terms of local control rate. Furthermore, the surgical approach did not increase the risk of major complications.
format Online
Article
Text
id pubmed-8763842
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87638422022-01-19 Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma Huang, Xiaozhun Liu, Yibin Xu, Lin Ma, Teng Yin, Xin Huang, Zhangkan Wang, Caibin Huang, Zhen Bi, Xinyu Che, Xu Front Surg Surgery Background: Radiofrequency ablation (RFA) is a curative modality for hepatocellular carcinoma (HCC) patients who are not suitable for resection. It remains controversial whether a surgical or percutaneous approach is more appropriate for HCC. Method: A search was performed on the PubMed, Web of Science, Embase, and Cochrane Library databases from the date of database inception until April 17, 2021. Studies reporting outcomes of comparisons between surgical RFA (SRFA) and percutaneous RFA (PRFA) were included in this study. The meta-analysis was performed using the Review Manager 5.3 and Stata 12.0 software. Result: A total of 10 retrospective studies containing 12 cohorts, involving 740 patients in the PRFA group and 512 patients in the SRFA group, were selected. Although the tumor size in PRFA group was smaller than the SRFA group (p = 0.007), there was no significant difference in complete ablation rate between the SRFA and PRFA groups (95.63% and 97.33%, respectively; Odds ratio [OR], 0.56; 95% confidence intervals [CI], 0.26–1.24; p = 0.15). However, the SRFA group showed a significantly lower local tumor recurrence than the PRFA group in the sensitivity analysis (28.7% in the PRFA group and 21.79% in the SRFA group, respectively; OR, 1.84; 95% CI, 1.14–2.95; p = 0.01). Pooled analysis data showed that the rate of severe perioperative complications did not differ significantly between the PRFA and SRFA groups (14.28% and 12.11%, respectively; OR, 1.30; 95% CI, 0.67-2.53; p = 0.44). There was no significant difference in the 1-, 3-, and 5-year overall survival rates, as well as the 1- and 3-year disease-free survival (DFS) between the PRFA and SRFA groups. The 5-year DFS of the PRFA group was significantly lower than the SRFA group (hazard ratio 0.73; 95% CI 0.54–0.99). Conclusion: Based on our meta-analysis, the surgical route was superior to PRFA in terms of local control rate. Furthermore, the surgical approach did not increase the risk of major complications. Frontiers Media S.A. 2022-01-04 /pmc/articles/PMC8763842/ /pubmed/35059430 http://dx.doi.org/10.3389/fsurg.2021.788771 Text en Copyright © 2022 Huang, Liu, Xu, Ma, Yin, Huang, Wang, Huang, Bi and Che. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Huang, Xiaozhun
Liu, Yibin
Xu, Lin
Ma, Teng
Yin, Xin
Huang, Zhangkan
Wang, Caibin
Huang, Zhen
Bi, Xinyu
Che, Xu
Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
title Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
title_full Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
title_fullStr Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
title_full_unstemmed Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
title_short Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
title_sort meta-analysis of percutaneous vs. surgical approaches radiofrequency ablation in hepatocellular carcinoma
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763842/
https://www.ncbi.nlm.nih.gov/pubmed/35059430
http://dx.doi.org/10.3389/fsurg.2021.788771
work_keys_str_mv AT huangxiaozhun metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT liuyibin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT xulin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT mateng metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT yinxin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT huangzhangkan metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT wangcaibin metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT huangzhen metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT bixinyu metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma
AT chexu metaanalysisofpercutaneousvssurgicalapproachesradiofrequencyablationinhepatocellularcarcinoma